Elizabeth is extremely smart, skilled and connected in the VC world and we are grateful for her presence supporting Vestiage.
Newport Beach, California (PRWEB) November 05, 2013
Vestiage Inc., the science-based anti-aging company, announced today that Life Sciences investor Elizabeth Edwards has joined the Vestiage Advisory Committee.
"We are very lucky to have Elizabeth Edwards join us and support Vestiage," said Scott Kimball, CEO of Vestiage. "She is one of the smartest people I've met in my life, and she is particularly interesting for us since she knows so much about the Life Sciences business and has been a successful venture investor in Life Science companies. I see her involvement with Vestiage as a major positive vote from a knowledgeable expert in the field."
Ms. Edwards has extensive experience in the Life Sciences business in sales, product marketing, finance, and operations at both large and emerging pharmaceutical and biotech companies. She is active in the Boston and Cambridge venture capital arena and has been an angel investor to several start-ups. She graduated from Harvard with a degree in Philosophy and obtained her MBA from UPENN/The Wharton Business School. She lives an active lifestyle participating in Ironman Triathlons and skiing.
The Vestiage Advisory Committee is made up of approximately 12 notable individuals across several disciplines including finance, sales, advertising, marketing, sports, medicine, consumer goods, natural products, ingredients, and entrepreneurship. The members include a Mayo Clinic trained anti-aging cardiologist, a Harvard trained aesthetic medical expert, a world famous Olympic athlete, former CEO's, COO's, CFO's and other executives from companies such as McDonalds, Wal*Mart, ColeHaan/Nike, Drexel Burnham Lambert, Fleetwood Enterprises, Rocket Dog, Pillsbury, Clorox, Proctor and Gamble, and Newell Rubbermaid. The CEO of Vestiage, Scott Kimball, is a former professional athlete and was a Wall Street Managing Director at Deutsche Bank and Bear Stearns, and founded a hedge fund and a private equity firm.
About Vestiage, Inc.
Vestiage (stock symbol "VEST") is a publicly traded anti-aging lifestyle company offering premium branded science-based cosmeceuticals and nutraceuticals. Vestiage is focused on the use of human stem cell, marine/ocean, and cutting edge botanically based science and ingredients to produce highly potent, elegantly formulated products with clinically proven ingredients. Using high potency and novel ingredient combinations, Vestiage creates and distributes cosmeceuticals such as Reluma (http://www.RelumaSkinCare.com) and multifunctional nutraceuticals through RegiMEN supplements and Monterey Bay Nutraceuticals (http://www.MontereyBayNutra.com). Vestiage brands address the top “in demand” anti-aging concerns of men and women. Vestiage research is focused on longevity and human performance science that covers both the cognitive and physical realms. As clinical results validate discoveries, Vestiage intends to apply new potential ingredients or ingredient formulations and combinations to its anti-aging products across brands. To learn more, visit the Company website, http://www.VestiageInc.com.
This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition, results of operations and business. These forward looking statements can be identified by the use of terms such as "believe," "expects," "plan," "intend," "may," "will," "should," "can," or "anticipates," or the negative thereof, or variations thereon, or comparable terminology, or by discussions of strategy. These statements involve known and unknown risks, uncertainties and other factors that may cause industry trends or our actual results to be materially different from any future results expressed or implied by these statements. Important factors that may cause our results to differ from these forward-looking statements include, but are not limited to: (i) changes in or new government regulations or increased enforcement of the same, (ii) unavailability of desirable acquisitions or inability to complete them, (iii) increased costs, including from increased raw material or energy prices, (iv) changes in general worldwide economic or political conditions, (v) adverse publicity or negative consumer perception regarding nutritional supplements, anti-aging or stem cell facial care products or stem cell technology in general, (vi) issues with obtaining raw materials of adequate quality or quantity, (vii) litigation and claims, including product liability, intellectual property and other types, (viii) disruptions from or following acquisitions including the loss of customers, (ix) increased competition, (x) slow or negative growth in the anti-aging or cosmetics, beauty, or nutritional supplement industry or the healthy foods or anti-aging channel, (xi) the loss of key personnel or the inability to manage our operations efficiently, (xii) problems with information management systems, manufacturing efficiencies and operations, (xiii) insurance coverage issues, (xiv) the volatility of the stock market generally and of our stock specifically, (xv) increases in the cost of borrowings or unavailability of additional debt or equity capital, or both, or fluctuations in foreign currencies, and (xvi) interruption of business or negative impact on sales and earnings due to acts of God, acts of war, terrorism, bio-terrorism, civil unrest and other factors outside of our control.